Observational studyBlood cancer discovery2024

A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.

Federico Stella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.